by Don McLean | Jul 18, 2019 | Blog
Using Real World Data in Pharmaceuticals: A Conversation with Chris Hurley by Staff writer The idea and practice of using real world data in the pharmaceutical industry has driven much conversation as of late. As groups like the Health Analytics Collective begin to...
by Don McLean | Jul 11, 2019 | Blog
Partner Spotlight: A Conversation with Julia Computing by Staff writer As an integral member of the Health Analytics Collective, Julia Computing is seen as the programming language of the future. We sat down with Andrew Claster, Director of Marketing &...
by Don McLean | Jun 27, 2019 | Blog
Pharmaceutical Industry News Roundup: June 2019 by Staff writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection of top stories to keep an eye on: FDA ‘open for business’ in considering real-world evidence,...
by Don McLean | Jun 13, 2019 | Blog
Developing Treatments for Rare Diseases – Reviewing Draft Guidance from the FDA by Amanda Beaster, PhD, Andrew Chervenak, PhD, Halina Chkourko Gusky, PhD, and Ingrid Hansen, MS New and updated regulatory guidances from the US Food and Drug Administration (FDA),...
by Don McLean | Jun 6, 2019 | Blog
11 Experts Discuss the Leadership Mindset of SOUL by Staff writer SOUL stands for bringing a Sense Of Urgency and Leadership to work each day. The SOUL of MMS comes to life as project work is completed on time and as risks and solutions are identified proactively. At...
by Don McLean | May 30, 2019 | Blog
Pharmaceutical Industry News Roundup: May 2019 by Staff writer Each month, MMS shares key stories on recent developments and news in the pharmaceutical industry. Here is a selection of top stories to keep an eye on: Submitting documents utilizing real-world data and...
